Henry A. Fernandez - 31 Dec 2024 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Henry A. Fernandez
Issuer symbol
RPRX
Transactions as of
31 Dec 2024
Net transactions value
+$37,487
Form type
4
Filing time
02 Jan 2025, 16:28:38 UTC
Previous filing
09 Dec 2024
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $37,487 +1,503 +2.8% $24.94 55,505 31 Dec 2024 Direct F1
holding RPRX Class A Ordinary Shares 58,200 31 Dec 2024 By Fernandez 2007 Children's Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.